NASDAQ : BIOC

Biocept, Inc.

$0.4349 USD

$0 (0.0%)

Volume
572.52K
Average Volume
2.16M
Market Capitalization
$450.79K
P/E Ratio
-0.01
Dividend Yield
0.00%
Price Target
Year High
$0.49
Year Low
$0.43
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.97
Company Overview

NASDAQ

Darrell Taylor

Medical - Diagnostics & Research

Healthcare

BIOC

50

US

USD

https://biocept.com

858 320 8200

09072V600

0001044378

Liquidity Metrics

1.37

2.97

2.83

2.34

0.00

Sales & Valuation

$25.86M

0.02

0.03

-0.03

-24.94

Profitability

-$56.78

-$32.09M

-124.09%

-124.57%

-138.49%

-103.93%

P/E Metrics

-0.01

0.00

0.00

Analyst Price Target & Rating

N/A

0/5

3 Analysts

%

Poll Results

About Biocept, Inc. (NASDAQ:BIOC) Stock

Biocept, Inc. is a company specializing in molecular diagnostics for cancer, primarily focused on developing and commercializing advanced diagnostic assays based on proprietary technology. These tests analyze circulating tumor cells (CTCs) and cell-free tumor DNA and RNA (ctDNA/ctRNA), primarily using standard blood samples. These assays furnish crucial insights to healthcare professionals, enabling them to identify specific genetic changes (oncogenic alterations) that qualify certain cancer patients for targeted therapies. This information is vital throughout the patient journey: at initial diagnosis, during disease progression, and for ongoing monitoring to detect the emergence of treatment resistance. Their diagnostic portfolio extends to various solid tumor types, including breast canc ... er, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. Beyond blood-based diagnostics, Biocept offers specialized testing services for cerebrospinal fluid (CSF), analyzing tumor cells, ctDNA, and ctRNA. These services cater to a broad spectrum of medical specialists, such as medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, and pathologists. Furthermore, the company supports pharmaceutical and biopharmaceutical companies, along with clinical research organizations (CROs), through its clinical trial and research services. Additionally, Biocept provides RT-PCR testing for COVID-19. In strategic partnerships, Biocept collaborates with CLEARED4 on a system designed to track and manage COVID-19 testing requirements and results for clients. Another collaboration involves Protean BioDiagnostics, Inc., focusing on research into the efficacy of Biocept's proprietary Target Selector molecular assay for determining EGFR status in non-small cell lung cancer (NSCLC) patients. Established in 1997, Biocept, Inc. operates from its headquarters in San Diego, California.

Frequently Asked Questions

What is the current Biocept, Inc. (BIOC) stock price?

Biocept, Inc.(NASDAQ:BIOC) stock price is $0.4349 in the last trading session. During the trading session, BIOC stock reached the peak price of $0.4349 while $0.4349 was the lowest point it dropped to. The percentage change in BIOC stock occurred in the recent session was 0.0% while the dollar amount for the price change in BIOC stock was $0.

BIOC's industry and sector of operation?

The NASDAQ listed BIOC is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of BIOC?

David S. Moskowitz | Vice President of Strategy & Corporation Communications
Pavel Tsinberg | Director of Technology Development
|
|
|

How many employees does BIOC have?

Number of BIOC employees currently stands at 50. BIOC operates from 9955 Mesa Rim Road, San Diego, CA 92121, US.

Link for BIOC official website?

Official Website of BIOC is: https://biocept.com

How do I contact BIOC?

BIOC could be contacted at phone #858 320 8200 and can also be accessed through its website. BIOC operates from 9955 Mesa Rim Road, San Diego, CA 92121, US.

How many shares of BIOC are traded daily?

The average number of BIOC shares traded daily for last 3 months was 2.16M.

What is the market cap of BIOC currently?

The market value of BIOC currently stands at $450.79K with its latest stock price at $0.4349